
United States · Biotechnology startup
Akadeum Life Sciences, Inc.
Funding reportedLast round: Series B
Akadeum Life Sciences, Inc.
is a biotechnology company based in Ann Arbor, Michigan, founded in 2014. The company focuses on advanced cell separation technologies, particularly through its proprietary Buoyancy Activated Cell Sorting (BACS) method. This innovative approach uses microscopic buoyant microbubbles to isolate target cells, offering a more efficient and gentle alternative to traditional magnetic separation techniques. Akadeum has been recognized as one of the "Top 10 Most Innovative Biotech Companies of 2023" by Fast Company. The company provides a range of products and services centered around its microbubble cell separation platform. This includes the AlerionTM Microbubble Cell Separation System, various research-use-only kits for specific cell types, and custom isolation solutions tailored to meet unique research needs. Akadeum primarily serves the life sciences sector, targeting cell therapy manufacturers, diagnostic laboratories, and research institutions, helping them overcome challenges in sample preparation and cell isolation.
Funding, as reported
What they build
Known for
cell therapy process developmenthealth careimmunology applicationsimmunology researchmicrobubble-based nucleic acid prepmicrobubble-based multiplex separationmanufacturinghealthcarecell separation validationmicrobubble cell sorting in g-rexresearch and clinical kitscell therapygmp-grade kitscell purity and recoverymicrobubble cell separationcell recovery optimization
Built with from their website
YoastYoast SEOGoogle MapsGoogle AnalyticsCookie NoticeElement UIWP RocketFacebook LoginCloudFlare CDNGoogle Tag Manager
HTTP/3DoubleClickGoogle Maps (Non Paid Users)Cloudflare Rocket LoaderBootstrapWP EngineHubspotPriority Hints
Add your raise, your deck and your story, and put Akadeum Life Sciences, Inc. in front of investors. Or tell us what we have wrong.